Antithrombin III (International)
In the US, Antithrombin III (antithrombin iii systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Antithrombin III Deficiency.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B01AB02
CAS registry number (Chemical Abstracts Service)
0052014-67-2
Therapeutic Category
Anticoagulant agent
Chemical Name
A glycoprotein fraction, obtained from human plasma. It is the major inhibitor of thrombin and other activated clotting factors, including factors IX, X, XI, and XII, and the cofactor through which heparin exerts its effect
Foreign Names
- Antithrombinum III (Latin)
- Antithrombin III (German)
- Antithrombine III (French)
- Antithrombina III (Spanish)
Generic Names
- Antithrombin III (OS: BAN)
- Antitrombina III (OS: DCIT)
- Antitrombin III umana concentrata (IS)
- AT-III (IS)
- Concentratum antithrombini III sanguinis humani (IS)
- Heparin Cofactor (IS)
- Major Antithrombin (IS)
- Antithrombin III Concentrate (PH: BP 2018)
- Antithrombin III Human (PH: USP 41)
- Antithrombinum III humanum densatum (PH: Ph. Eur. 9)
- Human antithrombin III concentrate (PH: Ph. Eur. 9)
Brand Names
- Aclotine 100 UI/ml
LFB, France - Anbinex
Grifols, Czech Republic; Grifols, Spain; Grifols, Poland; Grifols, Portugal; Grifols Arg., Argentina; Grifols Chile, Chile; Grifols Italia, Italy - Anbinex 1000 I.E.
Grifols, Germany - Anbinex 1000 IU
Dem Ilac, Turkey - Anbinex 500 I.E.
Grifols, Germany - Anbinex 500 IU
Dem Ilac, Turkey - Anthrobin P
Chemo-Sero-Therapeutic Research Institut Kaketsuken, Japan - Antithrombin III
Green Cross, South Korea - Antithrombin III Baxalta
Baxalta, Malta; Baxalta, Slovakia; CN Unifarm, Romania; Shire, Czech Republic; Shire Sweden, Sweden - Antithrombin III Baxter
Agmar, Croatia (Hrvatska) - Antithrombin III NF Baxalta
Baxalta, Canada; Baxter, Bulgaria - Antithrombin III NF Shire
Shire, Poland - Antitrombin III Baxalta
Shire Denmark, Denmark - Antitrombin III Baxter
Farmix, Serbia - Antitrombina III
Baxter-A, Italy - Antitrombina III UNC
Hemoderivados, Argentina - Antitrombine III Concentraat Immuno
Baxter Nederland, Netherlands - AT III
Baxter, Brazil - AT III Kedrion
Kedrion, Italy - AT III NF 1000
Baxalta Deutschland, Germany - AT III NF 500
Baxalta Deutschland, Germany - Atenativ
Octapharma, Czech Republic; Octapharma, Denmark; Octapharma, Spain; Octapharma, Finland; Octapharma, Macedonia; Octapharma, Norway; Octapharma, Poland; Octapharma, Sweden; Octapharma-A, Italy - ATenativ
Jana, Croatia (Hrvatska); Octapharma, Netherlands; Octapharma - Produtos Farmacêuticos Lda., Portugal - Atenativ 1000
Unifarm Medicom, Serbia - Atenativ 1000 I.E.
Octapharma, Germany; Octapharma Pharmazeutika, Austria - Atenativ 1500
Unifarm Medicom, Serbia - Atenativ 50 NE/ml
Octapharma, Hungary - Atenativ 500
Unifarm Medicom, Serbia - Atenativ 500 I.E.
Octapharma, Germany; Octapharma Pharmazeutika, Austria - Atenativ 500 IE
Octapharma, Switzerland - ATryn
GTC Biotherapeutics UK, Lithuania - Atryn
GTC, Estonia - Concentre d'Antithrombine III Baxter
Baxalta, Belgium - Kybernin 50 NE/ml
CSL Behring, Hungary - Kybernin P
CSL Behring, Czech Republic; CSL Behring, Spain; CSL Behring, Greece; CSL Behring, Italy; CSL Behring, Poland; Dexa Medica/CSL Behring, Indonesia; Farma-Tek, Turkey; PharmaSwiss, Croatia (Hrvatska) - Kybernin P 1000
CSL Behring, Germany - Kybernin P 1000IE
CSL Behring, Switzerland - Kybernin P 500
CSL Behring, Germany; CSL Behring, Serbia - Kybernin P 500 I.E./1000 I.E.
CSL Behring, Austria - Kybernin P 500IE
CSL Behring, Switzerland - Neuart
Japan Blood Products Organization, Japan - Nonthron
Nihon Seiyaku, Japan - Octati
Octapharma, Mexico - Prothromplex [+ Coagulation Factor IX, Human, + Coagulation Factor II, Human, + Protein C, Human, + Coagulation Factor VII, Human]
Baxalta, Norway - Prothromplex Immuno Tim4 [+ Prothrombin Complex, Human, + Protein C, Human, + Heparin]
Baxter, Spain - Prothromplex Total 600 I.E. [+ Prothrombin Complex, Human, + Protein C, Human, + Heparin]
Baxter Healthcare, Austria - Thrombotrol-VF
CSL Behring, Australia; CSL Behring, New Zealand
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.